NFIB and neoplasm: To investigate the tumourigenic properties of NFIB expressing cell lines, A2058− NFIB over-expressing human melanoma cells were injected into immune-compromised BALB/c Foxn1nu mice in two different injection sites (left and right rear flank), and were culled once the ethical tumour burden was reached.